(Q47738160)

5 February 2018

title

Feasibility and acceptance of simultaneous amyloid PET/MRI. (English)

1 reference

5 February 2018

15

Arno Villringer

1 reference

5 February 2018

Matthias L. Schroeter

6

object named as

Matthias L Schroeter

1 reference

5 February 2018

17

Karl-Titus Hoffmann

1 reference

5 February 2018

author name string

Lisa Schütz

1

1 reference

5 February 2018

Donald Lobsien

2

1 reference

5 February 2018

Dominik Fritzsch

3

1 reference

5 February 2018

Solveig Tiepolt

4

1 reference

5 February 2018

Peter Werner

5

1 reference

5 February 2018

Jörg Berrouschot

7

1 reference

5 February 2018

Dorothee Saur

8

1 reference

5 February 2018

Swen Hesse

9

1 reference

5 February 2018

Thies Jochimsen

10

1 reference

5 February 2018

Michael Rullmann

11

1 reference

5 February 2018

Bernhard Sattler

12

1 reference

5 February 2018

Marianne Patt

13

1 reference

5 February 2018

Hermann-Josef Gertz

14

1 reference

5 February 2018

Joseph Claßen

16

1 reference

5 February 2018

Osama Sabri

18

1 reference

5 February 2018

Henryk Barthel

19

1 reference

5 February 2018

publication date

19 July 2016

1 reference

5 February 2018

number of pages

8

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

5 February 2018

volume

43

1 reference

5 February 2018

issue

12

1 reference

5 February 2018

page(s)

2236-2243

1 reference

5 February 2018

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3462-X

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3462-X

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3462-X

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3462-X

Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3462-X

The role of positron emission tomography imaging in understanding Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3462-X

Tau imaging: early progress and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3462-X

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3462-X

Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3462-X

Multimodal imaging in Alzheimer's disease: validity and usefulness for early detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3462-X

Amyloid PET/MRI in the differential diagnosis of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3462-X

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3462-X

21 January 2018

Frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3462-X

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3462-X

Beta-amyloid imaging with florbetaben

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3462-X

Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3462-X

Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3462-X

Potential Clinical Applications of PET/MR Imaging in Neurodegenerative Diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3462-X

Medial temporal atrophy but not memory deficit predicts progression to dementia in patients with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3462-X

Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3462-X

Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3462-X

CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3462-X

Supporting evidence for using biomarkers in the diagnosis of MCI due to AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3462-X

Application of the National Institute on Aging-Alzheimer's Association AD criteria to ADNI

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3462-X

Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and education

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3462-X

An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3462-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3462-X

Alzheimer's Disease FDG PET Imaging Pattern in an Amyloid-Negative Mild Cognitive Impairment Subject.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3462-X

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3462-X

Critical Comparison of Different Biomarkers for Alzheimer's Disease in a Clinical Setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3462-X

Influence of the partial volume correction method on (18)F-fluorodeoxyglucose brain kinetic modelling from dynamic PET images reconstructed with resolution model based OSEM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3462-X

Combined PET/MR imaging in neurology: MR-based attenuation correction implies a strong spatial bias when ignoring bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3462-X

An SPM8-based approach for attenuation correction combining segmentation and nonrigid template formation: application to simultaneous PET/MR brain imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3462-X

Patient comfort during positron emission tomography/magnetic resonance and positron emission tomography/computed tomography examinations: subjective assessments with visual analog scales

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3462-X

Impact of MR-Based Attenuation Correction on Neurologic PET Studies.

21 January 2018

1 reference

12 December 2020

Positron emission tomographic studies of aging and Alzheimer disease.

1 reference

12 December 2020

Mild cognitive impairment due to Alzheimer disease in the community

1 reference

12 December 2020

Florbetaben to trace amyloid-β in the Alzheimer brain by means of PET.

1 reference

12 December 2020

Partial-Volume Effect Correction Improves Quantitative Analysis of 18F-Florbetaben β-Amyloid PET Scans

1 reference

12 December 2020

10.1007/S00259-016-3462-X

Identifiers

DOI

1 reference

5 February 2018

release_ens5u5nptfatfaqztxvykkk26y

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ens5u5nptfatfaqztxvykkk26y

24 November 2022

mapped directly with Wikidata item

1 reference

5 February 2018